Can a simple gas save lives in severe lung failure?
NCT ID NCT07334873
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding inhaled nitric oxide (iNO) to standard care helps adults with moderate-to-severe acute respiratory distress syndrome (ARDS) survive longer. About 536 participants will be randomly assigned to receive iNO or a placebo through their ventilator. The main goal is to see if iNO reduces deaths within 28 days and increases time off the ventilator.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARDS (MODERATE OR SEVERE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New inhaled drug hopes to heal lungs in ventilator patients
- New breathing machine approach aims to shield heart in lung failure patients
- Less food before flip: could cutting tube feedings prevent stomach issues in ICU patients?
- New device aims to wean ventilator patients faster
- Ventilator study aims to Fine-Tune breathing support for ICU patients